IMMUNE SYSTEM DISEASES
Clinical trials for IMMUNE SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new IMMUNE SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for IMMUNE SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR's diabetes cell therapy trial ends early
Disease control TerminatedThis early-stage study tested a new treatment called VCTX211 for people with type 1 diabetes. The goal was to see if implanting these special cells could help the body make insulin and reduce the need for insulin shots. Only 5 people took part, and the study was stopped early. Th…
Matched conditions: IMMUNE SYSTEM DISEASES
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug peresolimab tested for rheumatoid arthritis – study ends early
Disease control TerminatedThis study tested peresolimab, an experimental drug, in 491 adults with moderately-to-severely active rheumatoid arthritis who had not responded well to other treatments. The goal was to see if peresolimab could reduce joint pain and swelling better than a placebo. However, the s…
Matched conditions: IMMUNE SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC